Clinical Trials

AALL08B1 Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

ClinicalTrials.gov Identifier

NCT01142427

Principal Investigator

Anne–Marie Langevin MD

For more information about this study
View Details

About This Study

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.